Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dth.13757 http://scihub22266oqcxt.onion/10.1111/dth.13757 32495952!7300538!32495952     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Dermatol+Ther 2020 ; 33 (4): e13757 Nephropedia Template TP {{tp|p=32495952|t=2020. Recommendations for treatment of nail psoriasis during the COVID-19 pandemic |pdf=|usr=}}{{32495952}} gab.com Text Recommendations for treatment of nail psoriasis during the COVID-19 pandemic JO: Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32495952 #FOAvip The novel coronavirus disease 2019 (COVID-19) pandemic has resulted in a paradigm shift in disease management. Since immunosuppression may cause increased susceptibility to COVID-19, there is uncertainty as to whether systemically treated nail psoriasis patients are at increased infection risk. While specific data on nail psoriasis treatments and COVID-19 is lacking, we present clinical trial data on rates of upper respiratory infections, nasopharyngitis, viral infection, pneumonia and overall infections. Some systemic medications and biologics are associated with increased in infections risk compared to placebo in clinical trials. However, this data should be regarded cautiously since clinical trials on nail psoriasis, particularly controlled studies, are lacking. Our recommendations may be helpful in guiding physicians managing nail psoriasis patients during the COVID-19 pandemic. Twit Text FOAVip Recommendations for treatment of nail psoriasis during the COVID-19 pandemic ????Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32495952 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32495952 #FOAvip English Wikipedia <ref>{{Cite pmid|32495952}}</ref> Recommendations for treatment of nail psoriasis during the COVID-19 pandemic #MMPMID32495952 Ricardo JW; Lipner SR Dermatol Ther 2020[Jul]; 33 (4): e13757 PMID32495952show ga The novel coronavirus disease 2019 (COVID-19) pandemic has resulted in a paradigm shift in disease management. Since immunosuppression may cause increased susceptibility to COVID-19, there is uncertainty as to whether systemically treated nail psoriasis patients are at increased infection risk. While specific data on nail psoriasis treatments and COVID-19 is lacking, we present clinical trial data on rates of upper respiratory infections, nasopharyngitis, viral infection, pneumonia and overall infections. Some systemic medications and biologics are associated with increased in infections risk compared to placebo in clinical trials. However, this data should be regarded cautiously since clinical trials on nail psoriasis, particularly controlled studies, are lacking. Our recommendations may be helpful in guiding physicians managing nail psoriasis patients during the COVID-19 pandemic. |*Betacoronavirus[MESH] |*Disease Management[MESH] |*Pandemics[MESH] |*Practice Guidelines as Topic[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Humans[MESH] |Nail Diseases/epidemiology/*therapy[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Psoriasis/epidemiology/*therapy[MESH]Recommendations for treatment of nail psoriasis during the COVID-19 pa(epmc).pdf DeepDyve Pubget Overpricing